Covaxin approved for phase 2/3 trials on children
  • 3 years ago
The Drugs Controller General of India (DGCI) on Thursday approved coronavirus vaccine Covaxin for phase II/III clinical trial on children aged two to 18 years. The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur. For more, watch the full video.
Recommended